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Nucleotide signaling networks are key to facilitate 
alterations in gene expression, protein function and 
enzyme activity in response to diverse stimuli. 
Cyclic di-adenosine monophosphate (c-di-AMP) is 
an important secondary messenger molecule 
produced by the human pathogen Staphylococcus 
aureus and is involved in regulating a number of 
physiological processes including potassium 
transport. S. aureus must ensure tight control over 
its cellular levels as both high levels of the 
dinucleotide and its absence result in a number of 
detrimental phenotypes. Here we show that in 
addition to the membrane bound Asp-His-His and 
Asp-His-His associated (DHH/DHHA1) domain-
containing phosphodiesterase (PDE) GdpP, S. 
aureus produces a second cytoplasmic 
DHH/DHHA1 PDE Pde2. Although capable of 
hydrolyzing c-di-AMP, Pde2 preferentially 
converts linear 5’-phosphadenylyl-adenosine 
(pApA) to AMP. Using a pde2 mutant strain, pApA 
was detected for the first time in S. aureus, leading 
us to speculate that this dinucleotide may have a 
regulatory role under certain conditions. Moreover, 
pApA is involved in a feedback inhibition loop that 
limits GdpP-dependent c-di-AMP hydrolysis. 
Another protein linked to the regulation of c-di-
AMP levels in bacteria is the predicted regulator 
protein YbbR. Here, it is shown that a ybbR mutant 
S. aureus strain has increased acid sensitivity that 
can be bypassed by the acquisition of mutations in 
a number of genes, including the gene coding for 
the diadenylate cyclase DacA. We further show that 
c-di-AMP levels are slightly elevated in the ybbR 
suppressor strains tested as compared to the wild-
type strain. With this, we not only identified a new 
role for YbbR in acid stress resistance in S. aureus, 
but also provide further insight into how c-di-AMP 
levels impact acid tolerance in this organism. 
 
INTRODUCTION 
 The Gram-positive bacterium 
Staphylococcus aureus is persistently carried by 
about 30% of the human population (1). This 
colonization is often asymptomatic, but S. aureus 
can become pathogenic and cause various diseases 
ranging from skin and soft tissue infections to 
pneumonia and bacteremia (2). This 
microorganism has also developed resistance to 
many antibiotics, which has reduced the number of 
therapeutic choices available (3,4). Although 
methicillin resistant S. aureus (MRSA) is mostly 
associated with the hospital setting, community-
associated MRSA (CA-MRSA) strains have spread 
rapidly in some countries (3). 
 Bacteria have a remarkable ability to 
readily adapt to fluctuating environmental 
conditions and cope with periods of stress. Signal 
transduction pathways are crucial to achieving this 
flexibility, where stimuli are sensed, and signals 
relayed within the cell to trigger the induction of an 
appropriate response. Signaling nucleotides, 
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functioning as secondary messenger molecules, are 
known to regulate a diverse array of cellular 
networks in all forms of life. Cyclic adenosine 
monophosphate (cAMP) and cyclic di-guanine 
monophosphate (c-di-GMP) are amongst the best 
studied of these molecules, and regulate a number 
of physiological processes including carbon 
catabolism and the switch between a sessile and 
motile lifestyle, respectively (5). The functions of 
the stringent response alarmones guanosine 
tetraphosphate and pentaphosphate ((p)ppGpp) 
have also been extensively investigated. These 
nucleotides are produced under various stress 
conditions including nutrient limitation. They act to 
decrease the expression of genes required for active 
growth and increase the expression of amino acid 
synthesis and transporter genes (6). Although more 
recently discovered, an impressive effort has been 
made to elucidate the function of cyclic di-
adenosine monophosphate (c-di-AMP) in bacteria.  
The signaling molecule c-di-AMP is 
predominantly produced by Gram-positive bacteria 
belonging to the Firmicutes and Actinobacteria 
phyla, but can also be synthesized by some Gram-
negative bacteria (7-14). c-di-AMP is synthesized 
from two molecules of ATP via a condensation 
reaction requiring the activity of a diadenylate 
cyclase (DAC), and hydrolyzed by a 
phosphodiesterase (PDE) into 5’-phosphadenylyl-
adenosine (pApA), or two molecules of AMP 
(7,8,10,15-17). S. aureus produces a single DAC 
enzyme called DacA, which is encoded by the first 
gene in the dacA-ybbR-glmM operon (7,11). The 
third gene of this operon encodes the 
phosphoglucosamine mutase GlmM, a cytoplasmic 
enzyme that converts glucosamine-6-phosphate 
into glucosamine-1-phosphate (18-20). This 
product is subsequently used for the production of 
an early peptidoglycan synthesis intermediate. The 
second gene in the operon, ybbR, encodes a 
predicted membrane protein that has been shown to 
interact with, and influence the activity of DacA 
(21-23). However, there are conflicting reports as 
to whether YbbR stimulates or inhibits the activity 
of the cyclase. Therefore, a conclusive role for 
YbbR is still lacking. 
GdpP (also named YybT or Pde1) was the 
first c-di-AMP hydrolyzing enzyme identified in 
Bacillus subtilis (15). GdpP contains two N-
terminal transmembrane helices, followed by a 
cytoplasmic Per-Arnt-Sim (PAS) domain, a 
modified GGDEF domain and a DHH/DHHA1 
domain, which possesses phosphodiesterase 
activity (15). GdpP homologs have since been 
discovered in a range of microorganisms including 
Streptococcus pneumoniae, Listeria 
monocytogenes and S. aureus, and function to 
specifically degrade c-di-AMP into pApA 
(7,17,24,25). The absence of GdpP in S. aureus 
leads to an approximately 10-fold increase in 
cellular c-di-AMP levels, a reduced bacterial cell 
size and production of a peptidoglycan polymer 
with increased cross-linking (7). Further studies 
have also correlated levels of c-di-AMP in S. 
aureus with resistance to β-lactam antibiotics (7,26-
28). 
A cytoplasmic protein containing a stand-
alone DHH/DHHA1 domain, but lacking the 
sensory domains found in GdpP, has also been 
associated with the metabolism of c-di-AMP 
(14,24,29). In Borrelia burgdorferi, the 
DHH/DHHA1 domain containing protein DhhP, 
has been described as a c-di-AMP PDE and 
essential for growth (14). S. pneumoniae produces 
a homolog of DhhP named Pde2, which can 
hydrolyze c-di-AMP and pApA as well as 3’-
phosphoadenosine-5’-phosphate (pAp) to AMP 
and is essential for pathogenesis (24)(29). The 
Mycobacterium tuberculosis and Mycobacterium 
smegmatis homologs, MtbPDE and MtPDE 
respectively, have been shown to degrade both c-
di-AMP and pApA (30-33). A third class of c-di-
AMP PDE found in c-di-AMP producing 
microorganisms is a HD-domain containing 
enzyme (17,34). Similarly to GdpP, this PDE is an 
integral membrane protein and degrades c-di-AMP 
into pApA (17,34). 
 In this study, we further investigated the c-
di-AMP metabolism in S. aureus by examining the 
function of the DHH/DHHA1 PDE Pde2 and the 
membrane protein YbbR. We show that the S. 
aureus PDE Pde2 preferentially hydrolyzes pApA 
over c-di-AMP, leading in its absence to an 
accumulation of pApA. We also show that deleting 
ybbR in S. aureus does not significantly affect c-di-
AMP production or growth under standard growth 
conditions. However, its absence leads to increased 
acid sensitivity, which can be compensated by the 
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RESULTS 
An S. aureus pde2 mutant strain displays a 
growth defect in the early growth phase - Although 
HD-domain containing PDEs are not found in 
Staphylococcae, a stand-alone DHH/DHHA1 
domain protein and Pde2 ortholog is present in S. 
aureus. This protein corresponds to 
SAUSA300_1650 in S. aureus strain FRP5737 and 
will be from here on out referred to as Pde2. In 
order to assess the function of Pde2 in S. aureus, 
strain LAC*Δpde2::erm was constructed in which 
the pde2 gene was replaced by an erythromycin 
marker. When grown in TSB medium, 
LAC*Δpde2::erm exhibited a growth defect in the 
early stages of growth, similar to that observed for 
the gdpP mutant strain LAC*ΔgdpP::kan, but in 
contrast to the gdpP mutant, reached a similar 
density as the WT LAC* control culture at later 
time points (Fig. 1A). This growth defect could be 
complemented by expressing pde2 from its native 
promoter from the single site integration vector in 
strain LAC*Δpde2::erm pCL55-pde2 (Fig. 1B). 
Strain LAC*ΔgdpP::kanΔpde2::erm, deleted for 
both gdpP and pde2, exhibited a greater growth 
defect as compared to the single mutants at the early 
time points, with the culture reaching a similar 
density as the gdpP mutant strain at the 8 h time 
point (Fig. 1A). This growth analysis revealed that 
the pde2 and gdpP mutants have distinct growth 
phenotypes, and the additive growth defect 
observed in the double mutant suggests that Pde2 
might also be involved in the c-di-AMP metabolism 
of S. aureus.  
 
Deletion of pde2 in S. aureus leads to an increase 
in cellular c-di-AMP levels and increased 
oxacillin resistance - To directly assess the 
contribution of Pde2 to c-di-AMP metabolism in S. 
aureus, cytosolic extracts were prepared from WT 
LAC*, the isogenic pde2, gdpP single mutants and 
the gdpP/pde2 double mutant strains. As an 
additional control, strain LAC*dacAG206S was 
constructed, which produces a DacA variant with a 
glycine to serine change at amino acid residue 206. 
S. aureus strains containing this dacAG206S allele 
have been reported to produce lower amounts of c-
di-AMP (26). Next, the cellular c-di-AMP 
concentration were determined by LC-MS/MS as 
well as using an ELISA assay. As expected, 
decreased or increased amounts of c-di-AMP were 
found in extracts derived from the dacAG206S and 
gdpP mutant strains respectively, when compared 
to the WT control strain (Fig. 1C and 1D). Using 
both c-di-AMP detection methods (LC-MS/MS and 
ELISA), a slight but significant increase in the 
cellular c-di-AMP concentration was also observed 
for the pde2 mutant when compared to WT LAC*, 
with the levels in the double mutant found to be 
even greater than in the gdpP single mutant (Fig. 
1C and 1D). Finally, as assessed by ELISA, the c-
di-AMP levels were restored to wild-type levels in 
the pde2 complementation strain LAC*Δpde2::erm 
pCL55-pde2 (Fig. 1E), Altogether, these data 
suggest that Pde2 contributes to c-di-AMP 
metabolism in S. aureus. A correlation between c-
di-AMP levels and oxacillin resistance of MRSA 
strains has been observed in previous studies where 
strains with high and low dinucleotide levels 
exhibit increased and decreased resistance, 
respectively (7,26). To assess the contribution of 
Pde2 to oxacillin resistance, M.I.C EvaluatorTM 
strips were used to determine the susceptibility of 
the different strains to this antibiotic. The oxacillin 
MIC for WT LAC* was 4 μg/ml and as expected, 
the gdpP and dacAG206S mutants showed higher and 
lower resistances respectively, with MICs of >256 
μg/ml and 0.12 μg/ml. Similar to the gdpP mutant, 
the pde2 single and gdpP/pde2 double mutant 
strains also displayed an increased resistance to 
oxacillin with MICs of >256 μg/ml. It is however 
of note that although growth was observed along all 
concentrations of the antibiotic strip for the gdpP 
and pde2 single mutant strains, a halo, and area of 
reduced growth, was visible at concentrations 
above 4 μg/ml but not visible for the gdpP/pde2 
double mutant strain (data now shown). Taken 
together, these results indicate that Pde2 contributes 
to oxacillin resistance and the metabolism of c-di-
AMP in S. aureus. 
 
S. aureus Pde2 preferentially hydrolyzes pApA 
over c-di-AMP - To determine the substrate 
specificity of the S. aureus Pde2 enzyme, an N-
terminally His-tagged version of the protein was 
expressed and purified from E. coli, and used in in 
vitro enzyme activity assays. 1 M recombinant 
Pde2 was incubated for 2 h with 100 M ATP, c-
di-AMP or pApA (spiked with nM concentrations 
of the respective radiolabeled nucleotide) and 
reaction products analyzed by TLC. As a control, 
reactions were also set up with recombinant GdpP, 
known to specifically cleave c-di-AMP into pApA 
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(7,35). As expected, GdpP converted c-di-AMP 
into a single product, pApA, but did not hydrolyze 
ATP or pApA (Fig. 2). Pde2 was incapable of 
hydrolyzing ATP whereas 35% of the input c-di-
AMP, and 100 % of the input pApA was 
hydrolyzed, and based on analogy with other Pde2 
enzymes, likely converted to AMP (Fig 2). To 
confirm that c-di-AMP and pApA were converted 
to AMP, 100 µM unlabeled c-di-AMP or pApA 
substrates were incubated with Pde2, and the 
reaction products analyzed by LC-UV. This 
analysis confirmed that Pde2 converted both c-di-
AMP and pApA into AMP (data not shown). These 
initial experiments also indicated that the S. aureus 
Pde2 enzyme preferentially hydrolyzes pApA over 
c-di-AMP. To investigate this further, a time-course 
experiment was performed. Complete hydrolysis of 
200 μM pApA was observed within 1 h using 4 nM 
Pde2 (Fig 3A and 3B). Using this low enzyme 
concentration, no hydrolysis of c-di-AMP was 
observed within the 1 h incubation time (Fig. 3A 
and 3B), suggesting that the native substrate of the 
S. aureus Pde2 enzyme is pApA rather than c-di-
AMP. 
 
Deletion of pde2 from S. aureus results in 
increased cellular levels of pApA - We reasoned 
that if Pde2 also degrades pApA in vivo in S. 
aureus, it is likely that upon deletion of pde2, 
cellular levels of pApA would be elevated. 
Therefore, cellular extracts were prepared from the 
WT LAC* strain, gdpP and pde2 single mutants 
and the gdpP/pde2 double mutant strains, and 
pApA levels determined by LC-MS/MS analysis. 
Although pApA was not detectable in WT LAC* or 
the gdpP mutant, the nucleotide was readily 
detected in the pde2 deletion strain (Fig 3C). This 
result supports the in vitro enzyme activity assays 
and suggests that the degradation of pApA is the 
main cellular function of Pde2 in S. aureus. 
Surprisingly, pApA could also be detected in 
extracts prepared from the gdpP/pde2 double 
mutant strain (Fig. 3C), suggesting the presence of 
yet another enzyme that can convert c-di-AMP to 
pApA in S. aureus, or the existence of an alternative 
cellular pathway leading to the generation of pApA. 
 
pApA inhibits GdpP phosphodiesterase activity, 
whereas Pde2 activity is inhibited by ppGpp – The 
hydrolysis of c-di-AMP by Pde2 is extremely 
inefficient in vitro and may not be of physiological 
relevance. However, an increase in cellular c-di-
AMP levels was detected in a pde2 mutant S. 
aureus strain along with an increase in pApA levels 
(Fig.1C-E and Fig. 3C). It is possible that high 
levels of pApA may inhibit the activity of GdpP, 
thereby leading to an elevation of c-di-AMP levels 
in the cell, even if Pde2 is unable to degrade c-di-
AMP in vivo. To establish whether pApA can 
indeed inhibit the PDE activity of GdpP, enzyme 
reactions were set up with purified GdpP enzyme 
and 50 µM c-di-AMP (spiked with a nM 
concentration of radioactive c-di-AMP) and 
increasing concentrations of pApA. The reactions 
were incubated for 1 h and the c-di-AMP hydrolysis 
activity of GdpP assessed by TLC. This analysis 
revealed that pApA could indeed inhibit the GdpP-
dependent conversion of c-di-AMP in a dose-
dependent manner (Fig. 4A), and an IC50 value of 
78  2.34 μM was established (Fig. 4B). These data 
suggest that an accumulation of pApA in the cell 
might lead to a negative feedback loop that acts to 
reduce the rate of c-di-AMP hydrolysis by GdpP in 
S. aureus. This inhibition is similar to that observed 
for the Pseudomonas aeruginosa c-di-GMP PDE 
RocR by pGpG (36,37). 
 It has previously been shown that the c-di-
AMP PDEs YybT and GdpP of B. subtilis and S. 
aureus, respectively and the HD-domain PDE 
PgpH of L. monocytogenes are inhibited by ppGpp 
(15,34,35). To establish if S. aureus Pde2 is also 
inhibited by ppGpp, degradation of pApA by Pde2 
was assessed in the presence of an increasing 
concentration of ppGpp. This analysis revealed that 
Pde2 is inhibited by ppGpp in a concentration 
dependent manner (Fig. 4C), and an IC50 of 139  
5.6 μM was determined (Fig. 4D). This data 
indicate that the alarmone ppGpp can inhibit the 
activities of both the membrane bound c-di-AMP 
PDE GdpP and the cytoplasmic pApA PDE Pde2, 
and suggests an importance in limiting c-di-AMP 
and pApA hydrolysis under nutrient limiting and 
other stress conditions. 
 
Deletion of ybbR does not affect growth, oxacillin 
resistance or c-di-AMP levels in S. aureus under 
standard growth conditions - Besides Pde2, 
another protein that has been linked to the 
metabolism of c-di-AMP in various organisms is 
YbbR. To investigate the function of YbbR in S. 
aureus, the ybbR mutant strain LAC*ΔybbR was 
generated. The growth of this mutant was compared 
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to that of the WT LAC* strain under standard 
growth conditions in TSB medium, however no 
difference in growth was noted (Fig 5A). To 
investigate if the deletion of ybbR might affect the 
stability of the DacA cyclase, DacA levels were 
assessed by western-blot at the 2 h and 6 h time 
points. However, no significant difference in DacA 
protein levels was found between the WT and the 
ybbR mutant strain (Fig. 5B). Of note, the absence 
of YbbR in the mutant strain was confirmed by 
western-blot analysis using a YbbR-specific 
antibody (Fig. 5B). Next, to establish whether or 
not YbbR affects c-di-AMP or pApA levels in S. 
aureus, cytoplasmic extracts were prepared from 
overnight cultures of the WT and LAC*ΔybbR 
mutant strains, and subjected to LC-MS/MS and 
ELISA analysis. Levels of c-di-AMP, however, 
remained unchanged in the absence of YbbR (Fig. 
1C and 1D) and similar to the WT control strain, no 
pApA was detected in the mutant (Fig. 3C). 
Consistent with this, the ybbR mutant also had an 
identical oxacillin MIC of 4 μg/ml as observed for 
the WT LAC* strain. Taken together, these data 
show that under standard growth conditions, YbbR 
neither affects DacA protein levels, nor the cellular 
levels of c-di-AMP or pApA, or oxacillin resistance 
in S. aureus. 
 
The absence of YbbR results in increased acid 
sensitivity - The S. aureus ybbR mutant grew 
identically to the WT LAC* strain in TSB medium 
(Fig. 5A). In order to identify a growth phenotype 
and potentially unmask a function for YbbR in S. 
aureus, the WT LAC* strain and ybbR mutant were 
subjected to a phenotypic microarray and grown on 
several BioLog plates. A significant difference in 
respiration was observed between the WT and ybbR 
mutant when cultured in rich medium containing 
urea, and the pH lowered to 4.5. While it was not 
possible to obtain information on the exact urea and 
medium composition within this well, the data 
suggested a potential difference in the growth 
between the strains under acid conditions. To 
investigate this further, 10-fold dilutions of LAC* 
and LAC*ΔybbR cultures were spotted onto 
standard TSA pH 7.3 and TSA pH 4.5 plates. 
Interestingly, disruption of ybbR led to a decreased 
resistance to acid stress (Fig. 6A). To confirm that 
this acid sensitivity phenotype is due to the deletion 
of ybbR, the single site integration vector piTET-
ybbR, which allows for ybbR expression from the 
anhydrotetracyline (Atet) inducible promoter, was 
integrated into the ybbR mutant strain, to produce 
the complementation strain LAC*ΔybbR piTET-
ybbR (∆ybbR compl.). The empty piTET vector was 
also introduced into WT LAC* and LAC*ΔybbR 
yielding control strains LAC* piTET and 
LAC*ΔybbR piTET. Production of YbbR in the 
presence of Atet was confirmed by western-blot 
using a YbbR-specific antibody (Fig. 6B). It is of 
note, however, that even upon full induction with 
200 ng/ml Atet, the YbbR protein level was reduced 
in the complementation strain as compared to the 
LAC* piTET control strain (Fig. 6B). The acid 
sensitivity phenotype of the ybbR mutant was 
partially complemented in the LAC*ΔybbR piTET-
ybbR strain upon supplementing the medium with 
Atet (Fig 6A), all together indicating that deletion 
of ybbR does indeed lead to the acid sensitivity 
phenotype. 
 
The acid sensitivity of a ybbR mutant strain can 
be bypassed by compensatory mutations at 
multiple chromosomal locations - In an attempt to 
further understand the contribution of YbbR to 
acid-resistance in S. aureus, suppressor strains were 
raised by plating high cell density aliquots of 
LAC*ΔybbR cultures on TSA pH 4.5 plates. 
Colonies that had grown within 24 h were then 
further characterized. Increased acid tolerance was 
confirmed for ten of these suppressor strains, 
referred to as LAC*ΔybbR-S1 to S5 and 
LAC*ΔybbR-S7 to S11, by spotting serial dilutions 
of cultures on TSA pH 4.5 plates (Fig. 7). As 
observed for the WT LAC* strain, but in contrast to 
the ybbR mutant strain, a similar number of 
colonies was obtained for the suppressor strains on 
both plates (Fig. 7). Whole genome sequencing was 
then employed to identify potential compensatory 
mutations in these strains. Good sequence coverage 
was obtained for 8 different LAC*ΔybbR 
suppressor strains and their genome sequences 
compared to that of the WT LAC* and the 
LAC*ΔybbR mutant strain. This analysis revealed 
two high frequency and good quality sequence 
changes in strain LAC*ΔybbR when compared to 
strain LAC* (Table 1). These mutations were also 
present in all suppressor strains, indicating that 
these mutations must have been acquired during the 
construction of strain LAC*ΔybbR (Table 1). The 
different LAC*ΔybbR suppressor strains contained 
one or two additional high frequency and good 
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quality changes. Interestingly, suppressor strains 
LAC*ΔybbR-S1 and S2 contained a mutation in 
dacA resulting in a glycine to valine amino acid 
substitution at amino acid position 78 in the 
encoded protein. This amino acid is predicted to be 
located in the third transmembrane helix of the c-
di-AMP cyclase DacA. Strains LAC*ΔybbR-S3 
and S7 contained a mutation in proP, coding for a 
predicted proline/betaine transporter. LAC*ΔybbR-
S4 contained a mutation in glyA and escA coding 
for the serine hydroxymethyl-transferase GlyA and 
an ABC transporter ATP-binding protein, 
respectively. LAC*ΔybbR-S9 contained a mutation 
in a PilT domain-containing protein and finally 
strains LAC*ΔybbR-S10 and S11 contained 
mutations in a putative membrane associated zinc 
metallo protease (Table 1). In summary, this 
suppressor mutant analysis indicates that the acid-
sensitive phenotype observed in the ybbR mutant 
can be bypassed in multiple ways; one of which 
likely affects the function of the c-di-AMP cyclase 
DacA. 
 
A high c-di-AMP level S. aureus strain has 
increased and a low level strain, decreased acid 
resistance - It seemed likely that the DacAG78V 
variant found in two of the suppressor strains has 
altered cyclase activity, leading to a change in the 
cellular c-di-AMP levels. Elevated levels of the 
dinucleotide have previously been linked to 
increased resistance to acid stress in B. subtilis and 
Lactococcus lactis (15,38). To possibly unmask a 
correlation between c-di-AMP levels and acid 
resistance in S. aureus, WT LAC*, the high and low 
level c-di-AMP producing strains, 
LAC*ΔgdpP::kan and LAC*dacAG206S, as well as 
strain LAC*ΔybbR were cultured in TSB pH 7.3 or 
TSB pH 4.5, and growth monitored over 8 h. 
Whereas LAC*, LAC*ΔybbR and LAC*dacAG206S 
grew equally well in TSB pH 7.3, strain 
LAC*ΔgdpP::kan demonstrated the expected 
growth defect (Fig. 8A). When cultured in TSB pH 
4.5 however, strain LAC*ΔgdpP::kan grew better 
than WT, reaching a higher optical density at the 6 
and 8 h time points (Fig. 8B). In contrast, the 
LAC*ΔybbR and LAC*dacAG206S strains struggled 
to grow in TSB pH 4.5 (Fig. 8B). Of note, 
LAC*dacAG206S exhibited a clumping phenotype 
within 1.5 h under acid stress, LAC*ΔybbR at 2 h 
and WT at 4 h. No clumping was observed for strain 
LAC*ΔgdpP::kan. To confirm that the observed 
acid resistance and sensitivity phenotypes were due 
to a mutation in the respective genes, a 
complementation analysis was performed using 
strains LAC*dacAG206S pCL55-dacA (Fig. 8C), 
LAC* gdpP compl. (Fig. 8D) and LAC*ΔybbR 
piTET-ybbR (Fig. 8E) along with the appropriate 
control strains. Full complementation was observed 
for the gdpP complementation strain whereas 
partial complementation was observed for strain 
LAC*dacAG206S pCL55-dacA (Fig. 8C).The fact 
that the wild-type copy of dacA is expressed in 
addition to the mutated dacAG206S gene could 
explain why only partial complementation was 
observed. Partial complementation was also 
observed for the ybbR complementation strain (Fig. 
8E), but as shown earlier, reduced YbbR protein 
levels are produced by this strain as compared to 
WT LAC* (Fig. 6C). All together, these results 
suggest that high levels of c-di-AMP lead to 
increased acid tolerance whereas low levels of c-di-
AMP result in acid sensitivity.  
 
c-di-AMP levels increase in WT as well as ybbR 
mutant S. aureus strains upon exposure to acid 
stress - As described above, we observed a 
correlation between c-di-AMP levels and acid 
resistance in S. aureus; that is, a strain with 
increased levels of c-di-AMP is more resistant, 
while a low level strain has increased sensitivity to 
acid stress. Therefore, we set out to test if acid stress 
conditions would induce c-di-AMP production in 
WT S. aureus. This would point to the possible 
scenario where induction is blocked in the ybbR 
mutant strain, leading to increased acid sensitivity 
that can be rescued by the ybbR suppressor strain 
producing the DacAG78V variant. The WT S. aureus 
strain LAC* was grown in TSB pH 7.3, TSB pH 4.5 
and TSB pH 4.25, a pH at which the WT strain had 
a similar growth defect as the LAC*ΔybbR when 
grown in TSB pH 4.5. Cytoplasmic extracts were 
then prepared and c-di-AMP levels measured by 
ELISA. Cellular c-di-AMP levels were indeed 
observed to increase when S. aureus was 
propagated in low pH medium (Fig. 9A). Next, we 
assessed c-di-AMP levels in the WT, the ybbR 
mutant and the ybbR-S1 suppressor strain 
producing the DacAG78V variant following growth 
in TSB pH 7.3 or TSB pH 4.5 medium. When 
grown in TSB pH7.3 medium, the c-di-AMP levels 
in the suppressor strain ybbR-S1 was slightly but 
significantly increased as compared to the wild-
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type and ybbR mutant strains. Surprisingly, the c-
di-AMP levels were found to increase in both the 
ybbR mutant and suppressor strain when grown in 
TSB pH 4.5 as compared to TSB pH 7.3 (Fig. 9B). 
These results indicate that the induction of c-di-
AMP production is not blocked in the ybbR mutant 
strain. However, since a small but significant 
increase in the “basal” c-di-AMP level was noted 
for the LAC*ΔybbR-S1 suppressor strain when 
grown in TSB pH 7.3 medium (Fig. 9B), this might 
suggest that the DacAG206S variant has increased 
cyclase activity. Finally, to address if the increase 
in c-di-AMP production observed in the ybbR 
suppressor strain with a mutation in dacA is also 
observed in other suppressor strains, we determined 
the intracellular c-di-AMP levels of several other 
ybbR suppressor strains following their growth in 
TSB pH 7.3 or pH 4.5 medium. Interestingly the c-
di-AMP levels in all suppressor strains were 
slightly increased as compared to the WT LAC* 
strain as well as the ybbR mutant strain in TSB 
pH7.3 medium (Fig. 9C) and under acid stress 
conditions, the c-di-AMP levels remained slightly 
elevated in all suppressor strains (Fig. 9D). Taken 
together, these data highlight an important role for 
c-di-AMP in acid stress resistance in S. aureus.  
 
DISCUSSION 
The work performed in this study revealed a 
function of the second DHH/DHHA1 domain 
protein in S. aureus, which we have termed Pde2, 
as a c-di-AMP- and pApA-hydrolyzing PDE. While 
Pde2 can degrade both c-di-AMP and pApA in 
vitro, biochemical assays and measurements of 
intracellular nucleotide levels indicate that pApA is 
the preferred substrate (Fig. 1, Fig. 2 and Fig. 3). In 
the absence of Pde2, the intracellular pApA 
concentration increases drastically and, to the best 
of our knowledge, this is the first time that this di-
nucleotide has been detected in a bacterial cell (Fig. 
3C). As part of this study, we also established that 
pApA can inhibit the c-di-AMP hydrolyzing 
activity of GdpP in a dose-dependent manner (Fig. 
4A and B, Fig. 10). Hence, Pde2 plays an important 
role in controlling intracellular pApA 
concentrations in S. aureus, and prevents an 
increase in c-di-AMP levels either directly through 
its weak c-di-AMP hydrolase activity, or indirectly 
through the pApA-dependent inhibition of GdpP. It 
is, however, likely that the enzyme has additional 
functions and nucleotide hydrolase activities in the 
cell that will be discussed.  
Through recent studies, it has become 
apparent that stand-alone DHH/DHHA1-domain 
enzymes can act on a variety of different nucleotide 
substrates ranging from nanoRNAs (RNA 
molecules ≤ 5 nucleotides), pApA, pGpG, cyclic-
di-nucleotides and pAp, which is a by-product of 
sulfur assimilation and of acyl carrier protein 
production (39,40). The S. aureus Pde2 enzyme 
shares a high degree of sequence similarity with the 
B. subtilis nano-RNase A NrnA (also referred to as 
YtqI), M. tuberculosis Rv2837c (also referred to as 
MtbPDE or CnpB) and S. pneumoniae Pde2 (also 
referred to as PapP). The latter two enzymes have 
been shown to degrade c-di-AMP and pApA to 
AMP; but all three enzymes also have confirmed 
nanoRNase and pAp-phosphatase activities 
(24,29,30,32,33,39,41). Based on these findings, it 
seems likely that S. aureus Pde2 may also degrade 
pAp and function as a general nanoRNA 
ribonuclease in the cell.  
While the S. pneumoniae and S. aureus 
Pde2 enzymes hydrolyze pApA more efficiently 
than c-di-AMP (Fig. 2 and Fig. 3A and B) (24), this 
is not the case for all stand-alone DHH/DHHA1 
enzymes involved in the metabolism of c-di-AMP 
characterized to date. Similar turnover rates 
towards c-di-AMP and pApA have been reported 
for the M. tuberculosis Rv2837c enzyme (32). In 
addition, this enzyme can degrade c-di-GMP and 
pGpG and was therefore not only implicated in c-
di-AMP but also in c-di-GMP metabolism in M. 
tuberculosis (32). Detailed enzymatic in vitro 
studies combined with investigations into the effect 
that inactivation of these enzymes has on cellular 
nucleotide and ribonucleotide pools are therefore 
crucial in determining the actual physiological 
activities of DHH/DHHA1 domain enzymes. 
The detection of pApA in S. aureus extracts 
derived from the pde2 mutant strain (Fig. 3C) 
provides the first experimental support that this di-
nucleotide is a physiologically relevant substrate 
for this class of enzyme and present in the cell. 
While we did not determine the cell size and exact 
µM amount of pApA in the pde2 mutant strain, 
based on a comparison with the previously 
determined c-di-AMP amounts in a wild-type S. 
aureus strain grown under similar conditions, we 
estimate that pApA reaches a cellular concentration 
of around 25 µM in the pde2 mutant. It is possible, 
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that under certain conditions when Pde2 function is 
inhibited, pApA levels may also be high in a wild-
type strain. This is an interesting possibility, as it 
has previously been speculated that the c-di-AMP 
breakdown product pApA could potentially act as a 
nanoRNA source in bacteria (42), an increase in 
which can result in changes in gene expression 
through differential priming of transcription (43). 
Surprisingly, an accumulation of pApA was also 
observed in a S. aureus mutant strain lacking both 
GdpP and Pde2 (Fig. 3C), highlighting that besides 
these two enzymes, another c-di-AMP PDE might 
be present (Fig. 10). As GdpP and Pde2 are the only 
DHH/DHHA1 domain proteins annotated in the S. 
aureus genomes, an enzyme with another domain 
architecture must be responsible for this activity. 
Alternatively, pApA could be derived as a by-
product from a different cellular pathway (Fig. 10), 
an interesting possibility that will be investigated in 
future studies. 
We show here that pApA can inhibit the 
activity of the c-di-AMP PDE GdpP (Fig. 4A and 
B). This might be an alternative explanation as to 
why, upon deletion of Pde2, an increase in the 
concentration of c-di-AMP is evident in S. aureus 
(Fig. 3C). The regulation of GdpP is even more 
complex as its activity is also inhibited, at least in 
vitro, by the stringent response nucleotide ppGpp 
(15,35). Interdependencies between cellular 
(p)ppGpp and c-di-AMP levels have been reported 
in several studies (35,44). While the molecular 
mechanisms behind this have not yet been well 
studied, one direct link between these two signaling 
molecules appear to be the c-di-AMP hydrolyzing 
enzymes such as GdpP and, as shown in this study, 
the pApA-degrading enzyme Pde2 (Fig. 4C and D, 
and Fig. 10). The link between c-di-AMP and 
(p)ppGpp controlled pathways is, however, a lot 
more complex and not solely controlled by the 
inhibition of c-di-AMP and pApA metabolizing 
enzymes by (p)ppGpp, as it has also been shown 
that the absence of c-di-AMP leads to a toxic 
increase in (p)ppGpp levels (44). 
Our study has also provided further insight 
into the cellular function of YbbR (also referred to 
as CdaR). YbbR homologs have been shown to 
directly interact with DacA homologs (also referred 
to as CdaA) in other bacteria (21-23). In addition, 
an interaction between CdaA and GlmM has been 
reported, leading to the hypothesis that DacA, 
YbbR and GlmM form a three-protein complex 
(22,32) (Fig. 10). We have identified a new role for 
YbbR in acid-stress resistance in S. aureus, and also 
provide further information on how c-di-AMP 
levels impact acid tolerance in this organism (Fig. 
6 and Fig. 9).  
In this study, we show that a S. aureus 
gdpP mutant strain that produces high levels of c-
di-AMP displays enhanced acid resistance (Fig. 8B 
and 8D), as has been reported for L. lactis, L. 
monocytogenes and B. subtilis gdpP mutant strains 
(15,25,38). Expanding on this, we further show that 
a dacAG206S mutant S. aureus strain, which produces 
low levels of c-di-AMP, demonstrates decreased 
acid resistance (Fig 8B and C). Furthermore, c-di-
AMP levels increased in a wild-type S. aureus 
strain when grown in acidified medium (Fig. 9A), a 
response that likely helps this organism cope with 
this stress condition. S. aureus can colonize a 
variety of sites within the human host that vary in 
pH between 4.2 and 7.6 (45). It is therefore vital that 
the bacterium mounts a suitable response to survive 
these challenging conditions, and this work 
highlights that c-di-AMP likely plays an important 
role in this. There are a number of characterized 
mechanisms that bacteria utilize in an effort to 
survive acidic environments. These include 
expelling cytoplasmic protons through the F1F0-
ATPase, producing alkaline compounds in order to 
neutralize the cytoplasmic pH and importing 
osmolytes such as choline or proline (46,47). 
Microarray data from S. aureus cultured in medium 
acidified to pH 4.5 revealed that besides genes 
encoding urease and proton efflux pumps, oxidative 
stress response genes and the kdp and opuC 
operons, encoding the c-di-AMP receptor proteins 
KdpD and OpuCA, are upregulated (45,48-51). 
Although an intriguing correlation, understanding 
the mechanism through which elevated c-di-AMP 
levels contributes to the acid tolerance in S. aureus 
or other microorganisms awaits future studies. 
The ybbR mutant strain exhibited 
decreased acid resistance (Fig. 8) and therefore we 
expected this strain to produce low concentrations 
of c-di-AMP under acid stress conditions. 
Surprisingly, cellular c-di-AMP concentrations 
were increased in the ybbR mutant strain as 
compared to wild-type when grown in low pH 
medium (Fig. 9B). Whole genome sequencing of 
LAC*ΔybbR suppressor strains that had acquired 
the ability to grow on acidified medium, offered 
some insight into the mechanisms used by these 
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strains to survive in the absence of YbbR. All of 
these suppressor mutations caused a slight increase 
in the basal c-di-AMP levels in the cell when the 
bacteria were grown under our standard growth 
conditions in TSB pH7.3 medium (Fig. 9C), and we 
believe that this increase in c-di-AMP levels might 
help these bacteria to cope with the acid stress. For 
a number of the suppressor strains it is harder to 
speculate on the connection between their genomic 
alterations, the increase in c-di-AMP production 
under standard laboratory conditions, and how the 
mutation leads to a reversion in acid sensitivity. 
However, it is interesting to note that a premature 
stop codon was identified in escA, a gene encoding 
an ABC transporter ATP-binding protein and a 
frame shift mutation in the predicted membrane-
associated zinc metalloprotease RseP (Table 1). B. 
subtilis orthologs of these two proteins have been 
shown to function in the same cellular pathway, 
although a connection with the acid stress response 
is at this point not clear. It has been shown that the 
ABC transporter EcsAB is required for the activity 
of the intramembrane cleaving protease RasP (the 
RseP ortholog in B. subtilis) and escA and rasP 
mutants show similar signal sequence processing 
and protein secretion defects (52,53). Two 
independent mutations in an annotated 
proline/glycine betaine transporter were identified, 
one of which resulted in a premature stop codon. 
Osmolyte uptake is known to be important in 
maintaining pH homeostasis and for bacterial 
osmoprotection (47,54). It is possible that 
deactivation or decreased proline/glycine betaine 
transporter activity allows for the accumulation of 
a more efficient compatible solute. In fact, deletion 
of a putative glycine betaine transporter from 
Salmonella enterica serovar Typhimurium led to 
increased resistance to salt stress and low pH as 
long as trehalose was produced (55). Perhaps two 
of the most interesting LAC*ΔybbR suppressor 
strains obtained in two independent screens, 
contained the same valine to glycine substitution at 
amino acid position 79 in DacA. It is possible that 
this substitution may result in a change in the 
conformation of DacA, affect DacA dimerization, 
its interaction with GlmM or its ability to sense 
stimuli. Based on cellular c-di-AMP measurements, 
the ultimate consequence of this appears to be an 
increase in cyclase activity under “non-stressed” 
standard growth conditions (Fig. 9B). This increase 
in c-di-AMP activity may now allow a ybbR mutant 
strain to survive under acid stress conditions. 
Altogether, this work provides not only new 
insights into the c-di-AMP metabolism of S. 
aureus, but also opens up a number of exciting 
possibilities for future investigations. 
 
EXPERIMENTAL PROCEDURES 
Bacterial strains and culture conditions - 
Escherichia coli strains were cultured in Luria 
Bertani (LB) medium and S. aureus strains in 
tryptic soya broth (TSB) at 37°C with aeration, 
unless otherwise stated. All bacterial strains used in 
this study are listed in Table 2 along with the 
relevant antibiotics and inducers used for their 
propagation. For growth under acidic conditions, 
the pH of TSB, which usually has a pH of 7.3, was 
lowered to pH 4.5 or pH 4.25 with HCl and for 
growth on plates, 30 g agar per liter TSB was added 
before lowering the pH. 
 
Strain construction - E. coli and S. aureus strains 
used in this study are listed in Table 2 and primers 
used in Table 3. Plasmid pET28b-His-pde2 was 
constructed for the expression and purification of 
the N-terminally his tagged S. aureus Pde2 protein. 
To this end, the pde2 gene was amplified by PCR 
from LAC* chromosomal DNA using primers 
ANG2214 and ANG2215. The product was 
digested with NheI and EcoRI and ligated with the 
similarly digested vector pET28b. Plasmid 
pET28b-His-pde2 was initially recovered in E. coli 
XL1-Blue and then introduced into E. coli BL21 
(DE3) for protein production, yielding strains 
ANG3898 and ANG3899, respectively. Plasmid 
pET28-His-capASP was constructed for the 
expression and purification of the His-tagged 
Streptococcus pneumoniae c-di-AMP receptor 
protein CapA (56). To this end, the capA gene was 
amplified from Streptococcus pneumoniae strain 
D39 chromosomal DNA using primers ANG2034 
and ANG2035. The resulting PCR product was 
digested with NdeI and HindIII, and ligated with 
the similarly digested pET28b. The plasmid was 
then transformed into E. coli XL1-Blue yielding 
strain ANG3480, and subsequently introduced into 
E. coli strain BL21(DE3) for protein expression, 
giving strain ANG3481. Plasmid pET28b-ybbRnoTM 
was generated for the expression and purification of 
the soluble YbbR protein domains, a protein that 
was subsequently used for antibody production. 
The ybbR gene (minus the predicted 
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transmembrane region) was amplified from LAC* 
DNA using primers ANG1370 and ANG1371 and 
digested with BamHI and NcoI. The product was 
ligated into similarly digested pET28b and 
transformed into XL1-Blue yielding strain 
ANG2262 and subsequently into BL21(DE3) 
yielding strain ANG2281. 
In order to generate the erm marked pde2 mutant 
strain LAC*pde2::erm (ANG 3559), 1 kb DNA 
fragments up- and downstream of the pde2 gene 
were amplified by PCR from LAC* genomic DNA 
using primer pairs ANG2040/2041 and 
ANG2044/2045. The erythromycin antibiotic 
resistance gene ermC was amplified from plasmid 
pCN49 (57) using primers ANG2042 and 
ANG2043. The upstream DNA and ermC 
fragments were fused by splice overlap extension 
(SOE) PCR using primers ANG2040 and 
ANG2043 and the resulting PCR product was then 
fused to the downstream DNA fragment using 
primers ANG2040 and ANG2045. This PCR 
product was digested with EcoRI and KpnI and 
cloned into pIMAY digested with the same 
restriction enzymes, yielding plasmid 
pIMAYpde2::erm. The plasmid was initially 
recovered in E. coli strain XL-1 Blue and 
subsequently introduced into the dcm mutant E. coli 
strain DC10B (ANG2151), yielding strains 
ANG3544 and ANG3511. The pIMAYpde2::erm 
construct was then electroporated into S. aureus 
RN4220 yielding strain ANG3516 and 
subsequently into S. aureus LAC*, which was 
propagated at 28oC. Allelic exchange was 
performed as described by Monk et al. (58) finally 
yielding strain LAC*pde2::erm (ANG3559). The 
gdpP/pde2 double mutant strain 
LAC*gdpP::kanpde2::erm (ANG3726) was 
generated by transducing the gdpP::kan mutation 
from strain ANG1961 into strain ANG3359 using 
Phage Φ85 and successful transduction was 
confirmed by PCR using primers ANG2086 and 
ANG2087. The complementation strain LAC* 
Δpde2 pCL55-pde2 (ANG4128) was generated by 
first amplifying the pde2 gene (including its 
promoter) from LAC* genomic DNA using primers 
ANG2472 and ANG2473. The PCR product was 
digested with EcoRI and BamHI and ligated with 
the similarly digested plasmid pCL55. The 
resulting plasmid pCL55-pde2 was recovered in E. 
coli XL1-Blue and subsequently introduced into E. 
coli strain IM08B, yielding strains ANG4123 and 
ANG4125, respectively. The plasmid was isolated 
from strain ANG4125 and introduced and 
integrated into the geh locus of S. aureus 
LAC*Δpde2::erm (ANG3559) yielding strain 
LAC*Δpde2::erm pCL55-pde2 (ANG4128). As 
control strains, the empty pCL55 vector was 
isolated from strain IM08B pCL55 (ANG3732) 
(51) and introduced into strains LAC* and 
LAC*Δpde2::erm yielding strain LAC* pCL55 
(ANG3795) (51) and LAC*Δpde2::erm pCL55 
(ANG4127), respectively. The gdpP 
complementation strain LAC*gdpP compl. was 
generated by replacing the kanamycin marked 
deletion of LAC*ΔgdpP::kan (ANG1961) with a 
complete version of gdpP gene. First, the entire 
gdpP gene including 1kb up- and downstream 
fragments was amplified from LAC* genomic 
DNA using primers ANG2254 and ANG2255. The 
resulting PCR product was digested with KpnI and 
NotI, inserted into the similarly digested pIMAY 
plasmid and recovered in E. coli XL-Blue to yield 
strain ANG3962. The plasmid was then 
transformed into E. coli IM08B and subsequently 
introduced into LAC*ΔgdpP::kan (ANG1961). 
Allelic exchange was performed as described by 
Monk et al. yielding strain LAC*gdpP compl. 
(ANG4040). Repair of the gdpP locus was 
confirmed by PCR and sequencing. To generate the 
S. aureus ybbR deletion strain LAC*ybbR 
(ANG3301), 1 kb DNA fragments up- and 
downstream of ybbR were amplified from LAC* 
genomic DNA using primer pairs 
ANG1848/ANG1814 and ANG1815/ANG1816. 
The PCR products were fused by SOE PCR using 
primers ANG1848 and ANG1816, digested with 
EcoRI and KpnI and ligated with similarly digested 
pIMAY; yielding plasmid pIMAYybbR. The 
plasmid was recovered in E. coli XL1-Blue (giving 
strain ANG3990), shuttled through DC10B (strain 
ANG3991) and subsequently electroporated into 
RN4220 and LAC*, yielding strains ANG4003 and 
ANG4045 respectively. The allelic exchange was 
performed as described above yielding strain 
LAC*ybbR (ANG3301) and the ybbR deletion 
was confirmed by PCR using primers ANG1817 
and ANG1818. The plasmid piTET-ybbR for 
anhydrotetracycline (Atet) inducible expression of 
ybbR in S. aureus was generated by amplifying the 
ybbR gene from LAC* chromosomal DNA using 
primers ANG1908 and ANG1909. The PCR 
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product and plasmid piTET were digested with 
AvrII and SacII, ligated and then transformed into 
E. coli XL1-Blue yielding strain XL1-Blue piTET-
ybbR (ANG3472). The plasmid was subsequently 
introduced and integrated into the geh locus of S. 
aureus strain RN4220, yielding strain RN4220 
piTET-ybbR (ANG3547) and subsequently moved 
by phage transduction using phage Φ85 into strain 
LAC*ΔybbR to generate the ybbR 
complementation strain LAC*ΔybbR piTET-ybbR 
(ANG3548). As controls, strains LAC* piTET 
(ANG3988) and LAC*ΔybbR piTET (ANG3869) 
containing the empty piTET vector were produced. 
To this end, plasmid piTET was first integrated into 
the geh locus of S. aureus strain RN4220, yielding 
strain RN4220 piTET (ANG290) and subsequently 
moved by phage transduction using phage Φ85 into 
strain LAC* and LAC*ΔybbR, respectively. 
 An S. aureus strain producing a DacA 
variant in which the glycine at amino acid position 
206 is replaced with a serine (from here on out 
referred to as dacAG206S allele) has been shown to 
produce reduced levels of c-di-AMP (26). To 
generate the low c-di-AMP level S. aureus strain 
LAC*dacAG206S (ANG3664), primer pairs 
ANG2104/ANG2109 and ANG2106/2110 were 
used to amplify 1kb fragments upstream and 
downstream from the dacA Gly206 codon using 
LAC* genomic DNA in PCRs, and the resulting 
products were fused by SOE PCR using primers 
ANG2104 and ANG2110. Primer ANG2109 and 
ANG2110 were designed to introduce the Gly206 
to Ser substitution. The resulting PCR product was 
then digested with EcoRI and XmaI, and ligated 
into pIMAY digested with the same enzymes. 
Plasmid pIMAYdacAG206S was initially recovered 
into E. coli strain XL1-Blue to yield ANG3606 and 
the plasmid was shuttled through S. aureus RN4220 
to generate strain RN4220 pIMAY-dacAG206S 
(ANG3652) and subsequently introduced into 
strain LAC* to produce LAC* pIMAY-dacAG206S. 
(ANG3659) that was propagated at 28oC. The 
allelic exchange was performed as described above 
yielding strain LAC*dacAG206S (ANG3664). The 
substitution of the glycine to serine codon in dacA, 
as well as all other plasmid inserts, were verified by 
fluorescence-automated sequencing. To generate 
the complementation strain LAC* dacAG206S 
pCL55-dacA, the dacA gene (including its 
promoter) was amplified from LAC* genomic 
DNA using primers ANG1765 and ANG2474. The 
product was digested with EcoRI and BamHI and 
inserted into the similarly digested plasmid pCL55. 
Plasmid pCL55-dacA was recovered in E. coli 
XL1-Blue and subsequently introduced into E. coli 
IM08B, resulting in the strains ANG4124 and 
ANG4126 respectively. The plasmid was then 
electroporated into strain LAC* dacAG206S 
(ANG3664) yielding strain LAC* dacAG206S 
pCL55-dacA (ANG4130). 
 
Growth curves - S. aureus strains were grown 
overnight in TSB medium containing the relevant 
antibiotic. Overnight cultures of WT LAC* and the 
indicated mutant strains were diluted in fresh TSB 
medium to an A600 of 0.01 or diluted to an A600 of 
0.05 if strain LAC*gdpP::kan was included in the 
growth curve. Cultures were incubated at 37°C, 
with aeration, until an A600 of 1 was reached. Fresh 
TSB was inoculated with the starter culture to an 
A600 of 0.01 or 0.05 as before, and growth 
monitored for 8 h by taking A600 readings every 2 h. 
Growth curves in TSB pH 4.5 medium were 
performed as follows: S. aureus strains were grown 
overnight in TSB medium before diluting in TSB 
pH 4.5 to an A600 of 0.05. Cultures were incubated 
at 37°C with aeration for 3.5 h before diluting again 
into fresh TSB pH 4.5 medium to an A600 of 0.05. 
Growth was then monitored for 8 h by taking A600 
readings every 2 h. Alongside this, the same strains 
were cultured in TSB medium and treated similarly 
as a control. The first dilution was made into TSB 
medium but cultures were grown for 2.5 h before 
diluting into fresh TSB medium once more. For the 
pde2 growth complementation assay in TSB 7.3 
medium, overnight cultures of the indicated strains 
were diluted to an A600 of 0.01 and growth 
monitored for 10 h by taking A600 readings every 2 
h. All growth curves were performed in triplicate 
with average values and standard deviations 
plotted. 
 
Oxacillin minimum inhibitory concentrations – 
Overnight cultures of WT LAC* and LAC* mutant 
strains were diluted to an A600 of 0.1 prior to 
spreading on Mueller-Hinton agar plates containing 
2% NaCl. Oxacillin M.I.C EvaluatorTM 
(ThermoScientific) strips were then applied to the 
agar and the plates incubated at 35°C for 24 h. MIC 
values represent an average of three independent 
experiments. 
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Protein purifications - His-tagged S. aureus GdpP, 
Pde2 and YbbRnoTM proteins and the his-tagged B. 
thuringiensis DisA protein (DisABT) were purified 
from 1 or 2 L of E. coli BL21(DE3) cultures. 
Following overnight growth at 30°C, strains were 
diluted 1:20 and cultured to an A600 of 0.5-0.8. 
Protein expression was then induced with 0.5 mM 
isopropyl 1-thio-β-D-galactopyranoside (IPTG). 
Strains were incubated overnight at 16°C for GdpP 
and YbbRnoTM overexpression, at 37°C for 4 h in the 
case of Pde2 and overnight at 18°C for DisABT. 
Proteins were purified by nickel-affinity and size 
exclusion chromatography as previously described 
(7). His-tagged CabP from Streptococcoccus 
pneumonia was expressed and purified essentially 
as described by Bai et al. (56). Briefly, a 1L 
BL21(DE3) pET28b-His-capASP culture was grown 
at 37°C to an A600 of 0.6, protein expression 
induced with 0.1 mM IPTG for 4h at 24°C. Bacteria 
were collected by centrifugation, suspended in 20 
ml 50mM Tris pH 7.5, 500 mM NaCl, 10% glycerol 
lysis buffer containing 10 mM imidazole and cells 
lysed by French pressing. The His-CapASP protein 
was purified by nickel affinity chromatography, 
where the column was washed after protein loading 
with 10 column volumes lysis buffer containing 10 
mM, 20 mM and finally 30 mM imidazole and 
subsequently eluted in 4 ml lysis buffer containing 
250 mM imidazole. The protein was subsequently 
dialyzed at 4oC twice for 2h against 1L PBS pH 7.4 
buffer and finally overnight against 1 L PBS pH 7.4 
buffer containing 10% glycerol. Protein 
concentrations were determined using the Pierce 
BCA kit, snap frozen and stored at -80oC.  
 
Western blotting - Bacteria from 0.5 ml to 1 ml 
cultures of the different S. aureus strains were 
harvested by centrifugation and suspended in TM 
buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl2) 
containing 100 μg/ml lysostaphin and 20 μg/ml 
DNase. Samples were normalized for A600 readings 
of the original cultures; that is cells collected from 
a 1 ml culture with an A600 of 1 were suspended in 
15 μl TM buffer. Samples were incubated at 37°C 
for 30 minutes and subsequently mixed with an 
equal volume of 2x SDS protein sample buffer. 
This was followed by boiling the samples for 10 
minutes and centrifugation for 5 minutes. Samples 
were then separated on 12% SDS-polyacrylamide 
gels and transferred to PVDF membranes. DacA 
and YbbR were detected using rabbit polyclonal 
anti-DacA (35) or anti-YbbR antibodies (produced 
at Covalab as part of this study) at 1:10,000 and 
1:20,000 dilutions respectively, and SrtA detected 
using an rabbit polyclonal anti-SrtA antibody (59) 
at a dilution of 1:20,000. An HRP-conjugated anti-
rabbit IgG secondary antibody (Cell Signaling 
Technologies, Catalogue Nr. 7074) was used at a 
1:10,000 dilution. Blocking and antibody 
incubation steps were performed in the presence of 
10 g/ml human IgG to reduce unspecific antibody 
binding to S. aureus Spa and Spi proteins. Blots 
were developed using ClarityTM Western ECL 
Blotting Substrate (Bio-Rad) and imaged using the 
ChemiDocTM Touch Imaging System (Bio-Rad). 
Western blots were performed in triplicate and a 
representative result is shown. 
 
Quantification of c-di-AMP and pApA by LC-
MS/MS - Starter cultures of the WT LAC* S. 
aureus strain and the different mutant strains were 
prepared in 5 ml TSB medium and grown for 4 h at 
37°C, with aeration. The cultures were back-diluted 
to an A600 of 0.05 in 5ml TSB medium and grown 
overnight in the same conditions. Cells were 
harvested from the overnight cultures and bacterial 
cell extracts prepared and analyzed as described 
previously using 0.58 μM 13C15N isotope labeled c-
di-AMP as an internal standard (7). At the same 
time the dry weight of the bacteria from a culture 
aliquot was determined for normalization purposes. 
For pApA measurements, 0.58 μM 13C15N isotope 
labeled c-di-AMP was added to the samples after 
extraction and before the LC-MS/MS analysis to 
account for internal ion suppression. c-di-AMP and 
pApA concentrations within the samples were 
determined based on a standard curve produced 
with known concentrations of c-di-AMP and 
pApA, respectively. Values are reported as ng c-di-
AMP/mg cell weight or ng pApA/mg cell weight 
and the averages values and standard deviations 
from three samples were plotted. A two-tailed two 
sample equal variance Student’s T-test was used to 
determine statistically significant differences 
between c-di-AMP and pApA levels in WT versus 
mutant strains.  
 
Detection and quantification of nucleotides by 
LC-UV - 100 μM unlabeled c-di-AMP or pApA 
(BioLog) were mixed with 1 μM purified Pde2 
enzyme in 50 mM Tris-HCl, pH 7.5, 0.1 mM MnCl2 
and 20 mM KCl buffer, and incubated at 37°C for 
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2 h. Reactions were stopped by boiling for 10 
minutes and precipitated proteins subsequently 
removed by centrifugation. The LC-UV analysis of 
the reaction products was performed as previously 
described (60) with the following modifications. 
Instead of mass spectrometric analysis, a Dionex 
HPLC-UV system with a constant flow rate of 0.6 
ml/min and a wavelength at 259 nm was applied. 
Solutions with known concentrations of AMP 
(retention time 3.0 min), c-di-AMP (retention time 
8.6 min) and pApA (retention time 9.0 min) were 
used as calibrators. 
 
Synthesis of radiolabeled c-di-AMP and pApA - c-
di-AMP used in in vitro nucleotide conversion 
assays was synthesized by incubating 2 mM 
unlabeled ATP spiked with 9.99 nM 32P-labeled 
ATP (Perkin-Elmer) with 10 µM DisABT in 40 mM 
Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM MgCl2 
buffer. This reaction was incubated at 45°C for 24 
h, deactivated by heating to 95°C for 10 minutes 
and the protein removed by centrifugation at 13, 
000 rpm for 5 minutes. One mM c-di-AMP was 
converted to pApA using 3 μM GdpP in 50 mM 
Tris-HCl, pH 7.5, 0.1 mM MnCl2 and 20 mM KCl 
buffer and the samples were incubated at 37°C for 
2 h. Reactions were stopped as described above. 
Conversions were analyzed by spotting 1 μl of each 
reaction on a PEI-cellulose F TLC plate (Merck 
Millipore). The nucleotides were separated using a 
1:1.5 (v/v) saturated NH4SO4, 1.5 M KH2PO4, pH 
3.6 buffer and visualized with a FLA 7000 Typhoon 
PhosphorImager. 
 
In vitro GdpP and Pde2 enzyme activity assays - 
GdpP and Pde2 activity assays were performed 
using 50 mM Tris-HCl, pH 7.5, 0.1 mM MnCl2 and 
20 mM KCl buffer and incubated at 37°C. 
Reactions were stopped at the indicated times by 
heating the samples to 95°C for 10 minutes and 
subsequently removing the proteins by 
centrifugation at 13,000 rpm for 5 minutes. The 
activity of Pde2 was first assessed through 
hydrolysis reactions using ATP, c-di-AMP and 
pApA as substrates. 100 μM of each substrate 
spiked with a low nM concentration of radiolabeled 
substrate was incubated with 1 μM GdpP or Pde2 
for 2 h. This was performed twice with two separate 
preparations of purified Pde2 (four times in total). 
Time course experiments were initiated by 
incubating 200 μM c-di-AMP or pApA (again 
spiked with a low concentration of the respective 
radiolabeled substrate) with 4 nM Pde2 for 1 h. 5 μl 
samples were removed from each reaction at time 
0, 2.5, 5, 10, 15, 20, 30 and 60 minutes. This was 
performed twice with two separate preparations of 
purified Pde2 (four times in total). GdpP inhibition 
assays were performed by incubating 50 μM c-di-
AMP (spiked with radiolabeled c-di-AMP) with 0.3 
μM GdpP in the presence of pApA (Biolog) ranging 
from 0 to 0.6 mM for 1 h. Pde2 inhibition assays 
were performed by incubating 200 μM pApA 
(spiked with a low concentration of radiolabeled 
pApA) with 4 nM Pde2 in the presence of ppGpp 
(tebu-bio) ranging from 0 to 0.8 mM. Inhibition 
assays were performed in triplicate. Following heat 
inactivation and centrifugation, 1 μl from each 
reaction was spotted onto PEI-cellulose F TLC 
plates (Merck Millipore) and run in 1:1.5 (v/v) 
saturated NH4SO4 and 1.5 M KH2PO4, pH 3.6 
buffer. Conversions were visualized using a FLA 
7000 Typhoon PhosphorImager and quantified 
using the ImageQuantTL software. Values were 
calculated based on an average from at least 3 
individual experiments and plotted with standard 
deviations. 
 
Acid susceptibility assay and generation of 
suppressor strains - The indicated S. aureus strains 
were grown overnight at 37°C in 5 ml TSB. 
Cultures were normalized to an A600 of 5,10-fold 
serial dilutions made and 5 μl of the 10-1 to 10-7 
dilutions spotted onto TSA or TSA pH 4.5 plates 
containing 200 ng/ml Atet where indicated. To raise 
acid-resistant suppressor mutants, cultures of strain 
LAC*ΔybbR were grown overnight in TSB and 100 
μl of 10-1 and 10-2 spread onto TSA pH 4.5 plates. 
To confirm that the obtained colonies were indeed 
acid-resistant ybbR suppressor strains, several 
colonies were picked and grown overnight in TSB 
and the next day 5 μl of 10-1 to 10-6 dilutions spotted 
onto TSA pH 4.5 plates. A strain that was able to 
plate at the 10-6 dilution was considered a bone-fide 
suppressor strain and in this manner strains 
LAC*ΔybbR-S1 to S5 and LAC*ΔybbR-S7 to S11 
were generated. 
 
Whole genome sequencing - WT LAC*, 
LAC*ΔybbR, and LAC*ΔybbR suppressor strains 
were cultured overnight at 37°C, cells harvested 
and genomic DNA extracted. Genome sequencing 
for the S. aureus strain LAC* was performed by 
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MicrobesNG (http://microbesng.uk) using an 
Illumina Hi-Seq platform and a 250 bp paired end 
read kit. All other strains were sequenced at the 
Department of Microbiology and Immunobiology 
at the Harvard Medical School, using an Illumina 
Mi-Seq platform and a 150 bp paired end read kit. 
Sequence analysis was performed using the CLC 
Genomics work bench software package. First the 
LAC* reads were aligned against the published 
USA300 FPR3757 genome sequence (RefSeq 
accession number NC_007793.1), assembled into a 
reference contig and the USA300 FPR3757 
annotation and base numbering transferred onto the 
LAC* sequence. Next, the LAC*ΔybbR and 
LAC*ΔybbR suppressor strain Illumina reads were 
mapped onto the assembled LAC* sequence and 
high frequency (> 65%) and good quality base 
changes identified using the CLC Genomics 
Workbench software package and the data are 
summarized in Table 1. The Illumina short reads 
are deposited in the European Nucleotide Archive 
under the study accession numbers PRJEB14759 
for strain LAC* and PRJEB14723 for all other 
strains.  
 
c-di-AMP quantification by competitive enzyme 
linked immunosorbent assay (ELISA) - 5 ml TSB 
was inoculated with a single colony of WT LAC* 
or the indicated S. aureus mutant strains and 
incubated for 4 h at 37°C, with aeration. Next, the 
cultures were diluted to an A600 of 0.05 in 5 ml TSB 
and incubated overnight under the same conditions. 
For growth in acidified medium (pH 4.5 and pH 
4.25), 5 ml TSB was inoculated with single colonies 
of WT and mutant strains, and incubated overnight 
at 37°C, with aeration. Cultures were diluted to an 
A600 of 0.05 in 5 ml acidified TSB (and TSB pH 7.3 
as a control) and grown to an A600 of 0.7. Cells were 
harvested from overnight or exponential phase 
cultures, and washed three times with 1 ml 
phosphate-buffered saline (PBS), pH 7.4. Pellets 
were suspended in 1 ml lysis buffer (50 mM Tris, 
pH 8 containing 20 μg lysostaphin) and then 
incubated at 37°C for 15 minutes. Lysates were 
added to 0.5 ml glass beads and further lysed using 
a Fast-Prep instrument (FP120, MP Biomedicals, 
LLC) at setting 6 for 30 seconds. This was repeated 
twice, placing the samples on ice for 2 minutes 
between runs. Glass beads were removed by 
centrifugation at 17, 000 x g at 4°C for 5 minutes 
and the cleared cell lysate transferred to a fresh 
tube. Lysates were boiled for 10 minutes, debris 
removed by centrifugation and the supernatants 
transferred to a new tube. The protein concentration 
of each sample was determined using the BCA kit 
(Pierce) and cell lysates normalized to a 
concentration ranging from 0.3 to 0.75 mg/ml. The 
ELISA was performed as previously described 
(61). Briefly, the wells of a 96 well NUNC 
Maxisorp plate were coated with 100 μl of a 10 
μg/ml CabP protein solution in coating buffer 
(50mM Na2CO3, 50 mM NaHCO3, pH 9.6) and 
plates incubated overnight at 4°C. Wells were 
washed three times with PBS, pH 7.4 containing 
0.05% Tween 20 (PBST) and blocked with 5% 
BSA in PBS. Next the control samples and S. 
aureus extracts (in triplicate) were added to the 
plate. To prepare the control samples, c-di-AMP 
(BioLog) was diluted two-fold in 50 mM Tris pH 8 
buffer from 200 nM to 3.125 nM. The same volume 
of biotinylated c-di-AMP (BioLog) was added to 
each sample to give a final concentration of 25 nM. 
Next, 100 μl of these control and S. aureus extracts 
samples were added to the coated ELISA plate. 100 
μl of lysis buffer only was added as a background 
reading control and the plate was then incubated at 
room temperature for 2 h. After washing the wells 
three times with 200 μl PBST, 100 μl of the 
PierceTM High Sensitivity Streptavidin solution 
(ThermoFisher Scientific) diluted 1:5,000 or 
1:10,000 in PBS was added to the wells and the 
plate incubated at room temperature for 1 h. Wells 
were washed again three times with 200 μl PBST. 
10 mg of o-Phenylenediamine dihydrochloride 
(OPD) (SIGMA-ALDRICH) was dissolved in 20 
ml citrate buffer, pH 5 containing 20 μl H2O2, and 
100 μl added as substrate to each well. The plate 
was incubated at room temperature for 30 minutes 
and the reaction stopped by the addition of 100 μl 2 
M H2SO4. The A490 was measured on a plate reader 
and buffer only readings subtracted from controls 
and buffer/lysostaphin readings subtracted from 
samples. The absorbance readings for the c-di-
AMP standard control samples were used to 
generate a second order polynomial calibration 
curve and the obtained quadratic equation was used 
to determine the c-di-AMP levels in the S. aureus 
extracts. The nM of c-di-AMP were converted into 
ng c-di-AMP/mg protein, and average values and 
standard deviations from three samples plotted. A 
two-tailed two sample equal variance Student’s T-
test was used to determine statistically significant 
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differences between c-di-AMP and pApA levels in 
WT versus mutant strains.  
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TABLES 
Table 1: Single nucleotide variants and deletions identified in strain LAC*ybbR (ANG3301) and eight 











1706409 SNV G A 100 37.33 SAUSA300_1561, Iron 
transporter of the 
NRAMP family, MntH 
Ala367Val 








SNV A C 95.83 35.3 SAUSA300_2113, c-di-






SNV A C 91.67 34.67 SAUSA300_2113, c-di-
























631695 SNV C T 100 35.43 SAUSA300_0558, 



























1Reference position is based on the USA300 FPR3757 genome sequence (NC_007793.1). 2Type of 
mutation with SNV indicating single nucleotide variant, DEL nucleotide deletion and INS nucleotide 
insertions. 3Ref: indicates base in reference genome and 4allele indicates base at the same position in 
sequenced strain. 5Freq.: Denotes frequency at which base changes were found in the sequence data and 
6Av. quality denotes the average quality score. 7AA change denotes (where applicable) the resulting amino 
acid change in the protein found in the reference strain as compared to the sequenced strain.  
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Table 2: Bacterial strains used in this study 
Strain Name Description Reference 
 Escherichia coli strains  
XL1-Blue Cloning strain, TetR, ANG127 Stratagene 
BL21(DE3) Protein expression strain – ANG191 Novagen 
DC10B Cloning strain, dcm, - ANG2151 (58) 
DH10B pIMAY DH10B pIMAY; CamR - ANG2154 (58) 
IM08B E. coli strain with S. aureus restriction modification system; 
ANG3724 
(62) 
ANG243 XL1-Blue pCL55; S. aureus single-site integration vector: 
AmpR 
(63) 
ANG284 XL1-Blue piTET; AmpR (64) 
ANG1824 XL1-Blue pET28b; KanR Novagen 
ANG1861 BL21(DE3) pET28b-gdpP84-655; KanR (7) 
ANG2262 XL1-Blue pET28b-ybbRnoTM; KanR This study 
ANG2281 BL21(DE3) pET28b-ybbRnoTM; KanR This study 
ANG3048 BL21(DE3) pET28b-disABT-His; KanR (65) 
ANG3472 XL1-Blue piTET-ybbR; AmpR This study 
ANG3480 XL1-Blue pET28b-His-cabPSP; KanR This study 
ANG3481 BL21(DE3) pET28b-His-cabPSP; KanR This study 
ANG3511 H10B pIMAYΔpde2::erm; CamR This study 
ANG3544 XL1-Blue pIMAYΔpde2::erm; CamR This study 
ANG3732 IM08B pCL55; AmpR (51) 
ANG3898 XL1-Blue pET28b-His-pde2; KanR This study 
ANG3899 BL21(DE3) pET28b-His-pde2; KanR This study 
ANG3606 XL1-Blue pIMAY-dacAG206A; CamR This study 
ANG3962 XL1-Blue pIMAY-gdpP; CamR This study 
ANG3963 IM08B pIMAY-gdpP; CamR This study 
ANG3990 XL1-Blue pIMAYΔybbR; CamR This study 
ANG3991 DC10B pIMAYΔybbR; CamR This study 
ANG4123 XL1-Blue pCL55-pde2; AmpR This study 
ANG4124 XL1-Blue pCL55-dacA; AmpR This study 
ANG4125 IM08B pCL55-pde2; AmpR This study 
ANG4126 IM08B pCL55-dacA; AmpR This study 
   
 Staphylococcus aureus strains  
RN4220 Restriction deficient derivative of 8325-4 (66) 
LAC* CA-MRSA LAC strain; ErmS; ANG 1575  (67) 
ANG290 RN4220 piTET  This study 
ANG1961 LAC*ΔgdpP::kan; KanR (7) 
ANG3301 LAC*ΔybbR This study 
ANG3516 RN4220 pIMAYΔpde2::erm; CamR ErmR 28oC This study 
ANG3547 RN4220 piTET-ybbR; CamR This study 
ANG3548 LAC*ΔybbR piTET-ybbR; CamR This study 
ANG3559  LAC* Δpde2::erm; ErmR This study 
ANG3652 RN4220 pIMAY-dacAG206S; CamR 28oC This study 
ANG3659 LAC* pIMAY-dacAG206S; CamR 28oC This study 
ANG3664 LAC*dacAG206S This study 
ANG3726 LAC*ΔgdpP::kan Δpde2::erm; KanR ErmR This study 
ANG3817 LAC*ΔybbR-S1 (suppressor strain 1 ) This study 
ANG3818 LAC*ΔybbR-S2 (suppressor strain 2) This study 
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ANG3819 LAC*ΔybbR-S4 (suppressor strain 4) This study 
ANG3820 LAC*ΔybbR-S5 (suppressor strain 5) This study 
ANG3821 LAC*ΔybbR-S7 (suppressor strain 7) This study 
ANG3822 LAC*ΔybbR-S8 (suppressor strain 8) This study 
ANG3823 LAC*ΔybbR-S9 (suppressor strain 9) This study 
ANG3824 LAC*ΔybbR-S10 (suppressor strain 10) This study 
ANG3825 LAC*ΔybbR-S11 (suppressor strain 11) This study 
ANG3855 LAC*ΔybbR-S3 (suppressor strain 3) This study 
ANG3869 LAC*ΔybbR piTET; CamR This study 
ANG3795  LAC* pCL55 (51) 
ANG3988  LAC* piTET This study 
ANG4003 RN4220 pIMAYΔybbR; CamR, 28oC This study 
ANG4040 LAC*gdpP compl. This study 
ANG4045 LAC* pIMAYΔybbR; CamR, 28oC This study 
ANG4127 LAC*Δpde2 pCL55; CamR This study 
ANG4128 LAC*Δpde2 pCL55-pde2; CamR This study 
ANG4129 LAC*dacAG206S pCL55; CamR This study 
ANG 4130 LAC*dacAG206S pCL55-dacA; CamR This study 
Antibiotics were used at the following concentrations: for E. coli cultures: ampicillin (AmpR) 100 μg/ml, 
chloramphenicol (CamR) 10 μg/ml, and kanamycin (KanR) 30 μg/ml; for S. aureus cultures: 
chloramphenicol (CamR) 10 μg/ml for plasmids and 7.5 μg/ml for integrated plasmids, erythromycin 
(ErmR) 10 μg/ml and kanamycin (KanR) 90 μg/ml. The inducer anhydrotetracycline (Atet) was used at a 
concentration of 200 ng/ml in agar and 50 ng/ml in broth.  
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Table 3: Primers used in this study 
 
Restriction site sequences are underlined. 
Primer Nr. Name Sequence 
ANG1370 R_YbbRnoTM CGGGATCCCGTTTTACATTTATATAAGCCTTCGTTTCA
C 
ANG 1371 F_YbbRnoTM CATGCCATGGCTGGTAATCTTGGTCAAAAGTCTAGTA
AAAC 
ANG1765 F_EcoRI_dacA GCGCGAATTCTATAAAGTATATTTTGCTTTTTGC 
ANG1848 F_KpnI_YbbRdel1 GCGCGGTACCAATTGTAACGAGTATCCTTG 
ANG1814 R_YbbRdel1 GCCTTCGTTTCAAATCTCAAGCCCCATTTACTTTC 
ANG1815 F_YbbRdel2 GGCTTGAGATTTGAAACGAAGGCTTATATAAATGTA 
ANG1816 R_EcoRI_YbbRdel2 GCGCGAATTCAACGATATGTCCAGATTGTTCTCC 
ANG1817 F_YbbRdel_check GCAATGATTATTCAAGGCACGAAG 
ANG1818 R_YbbRdel_check CCCATATCGCGTGTTAAATATGC 
ANG1908 F_AvrII_YbbR GCGCCCTAGGCATTGGTTTGGCACACGCTTTC 
ANG1909 R_SacII_YbbR GCGCCCGCGGTTATTTTACATTTATATAAGCCTTCG 
ANG2034 F_NdeI_CabP_Nhis TTTCATATGTCAGATCGTACGATTGGAATTTTGGGC 
ANG2035 R_HindIII_CabP TTTAAGCTTACGAATTCAATGCTACTAGGGTATCC 









ANG2045 F_KpnI_1650del3 GCGCGGTACCCCAATAAATAACTGACCAGTGAGCC 
ANG2086 F_1650del_check CGGAAATCGTGAAGATGTGCAGATTG 
















ANG2472 F_EcoRI_1650 GCGCGAATTCGAACTTAGCAGAGAAAATAGGCATAAG    
ANG2473 R_BamHI_1650 GCGCGGATCCTTAGTTAAGTTTTGTGCGTAAAGCTG     
ANG2474 R_BamHI_dacA GCGCGGATCCTTATTTCACACCTTTCTTTTGAAAGCGT
G      
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FIGURE 1. An S. aureus pde2 mutant has a slight growth defect and increased cellular c-di-AMP 
levels. A and B, bacterial growth curve. A, Cultures of WT LAC* and the indicated mutant strains were 
diluted to an A600 of 0.05, grown to an A600 of 1, and back-diluted again to an A600 of 0.05 with this time 
point set to time = 0. Growth was subsequently monitored over an 8 h period and average A600 readings and 
standard deviations from three independent experiments plotted. B, Overnight culture of LAC* (WT) and 
the pde2 mutant strain containing the vector pCL55 as well as the pde2 complementation strain were diluted 
to an A600 of 0.01 and growth monitored over 10 h. Average A600 readings and standard deviations from 
three independent experiments are plotted. C, determination of intracellular c-di-AMP levels by LC-
MS/MS. WT LAC* and the indicated mutants were grown overnight in TSB medium, cell extracts prepared 
and c-di-AMP levels determined by LC-MS/MS. The nucleotide levels are reported as ng c-di-AMP/mg 
cell dry weight and the average values and standard deviations from three independent experiments plotted. 
D, determination of intracellular c-di-AMP levels by ELISA. The same strains as in C were grown overnight 
in TSB medium, cell extracts prepared and c-di-AMP levels determined by ELISA. The nucleotide levels 
are reported as ng c-di-AMP/mg protein and the average values and standard deviations from three 
independent experiments plotted. E, determination of intracellular c-di-AMP levels by ELISA. Cell extracts 
were prepared from LAC* (WT) and the pde2 mutant strain containing the vector pCL55 as well as the 
pde2 complementation strain and c-di-AMP levels determined by ELISA. The nucleotide levels are 
reported as ng c-di-AMP/mg protein and the average values and standard deviations from four independent 
experiments plotted. Statistical analysis was performed using an unpaired Student’s t-test where one 
asterisk (*), two asterisks (**) or three asterisks (***) indicate differences between WT and mutant strains 
with p-values of <0.05, <0.01 or <0.001, respectively. 
 









FIGURE 2. Pde2 degrades both c-di-AMP and pApA. A, GdpP and Pde2 enzyme activity assays. 100 
μM ATP, c-di-AMP or pApA spiked with a low nM concentration of the respective radiolabeled nucleotide 
were incubated for 2 h at 37°C in the absence of enzyme, or with 1 μM purified GdpP or Pde2. The reaction 
products were separated by TLC and radioactive signals detected with a phosphorimager. Substrate 
nucleotides are shown on top and nucleotide products are listed along the left of the figure. A representative 
image from four independent experiments is shown. B, quantification of GdpP and Pde2 nucleotide 
hydrolysis activity. The % c-di-AMP or pApA substrate hydrolysis by GdpP and Pde2 was determined by 
quantification of the radioactive signal of TLC plates shown in A, and the average value and standard 
deviations from four experiments are plotted.  
 
 





FIGURE 3. Pde2 preferably hydrolyzes pApA over c-di-AMP and its deletion leads to an 
accumulation of pApA. A, Pde2 enzyme activity time course experiment. 200 μM pApA or c-di-AMP 
spiked with a small concentration of the respective radiolabeled nucleotide was incubated with 4 nM 
purified Pde2 at 37°C. Samples were removed at timed intervals and analyzed by TLC as described in 
Figure 2. B, quantification of c-di-AMP and pApA hydrolysis by Pde2. The radioactive signals of the input 
nucleotide were quantified, the % c-di-AMP or pApA substrate hydrolysis calculated and the average values 
and standard deviations from six independent experiments plotted. C, determination of intracellular pApA 
levels by LC-MS/MS. WT LAC* and the indicated mutants were grown overnight in TSB medium, cell 
extracts prepared and pApA levels determined by LC-MS/MS as described in the experimental procedure 
section. The nucleotide levels are reported as ng pApA/mg cell dry weight and the average values and 
standard deviations from three independent experiments were plotted. Statistical analysis was performed 
using an unpaired Student’s t-test where three asterisks (***) indicate differences between WT and mutant 
strains with a p-value of <0.001. 
 





FIGURE 4. GdpP phosphodiesterase activity is inhibited by pApA and Pde2 activity by the alarmone 
ppGpp. A, GdpP enzyme activity in the presence of increasing concentrations of pApA. 50 μM c-di-AMP 
spiked with a nM amount of radiolabeled c-di-AMP was incubated for 1 h at 37°C with 0.3 μM GdpP and 
increasing concentrations of pApA ranging from 0 to 0.6 mM. The reaction products were separated by 
TLC and the radioactive signal detected using a phosphorimager. Experiments were performed in triplicate 
and a representative TLC plate is shown. B, quantification of c-di-AMP hydrolysis by GdpP in the presence 
of increasing amounts of pApA. The radioactive signal from plates shown in panel A was quantified, the % 
c-di-AMP hydrolysis calculated and the average values and standard deviations from three independent 
experiments plotted. The data were fitted and the IC50 determined using the dose response inhibition 
analysis in GraphPad Prism. C, Pde2 enzyme activity assay and TLC analysis. 200 μM pApA spiked with 
radiolabeled pApA was incubated for 1 h at 37°C with 4 nM Pde2 and increasing concentrations of ppGpp 
ranging from 0 to 0.8 mM. TLC plates were analyzed as described in panel A and a representative image 
from thee independent experiments is shown. D, quantification of pApA hydrolysis by Pde2 in the presence 
of increasing concentrations of ppGpp. The radioactive signal from panel C was quantified, the % pApA 
hydrolysis determined and the average values and standard deviations from three independent experiments 
plotted. The data were fitted and IC50 determined using the dose response inhibition analysis. 
  







FIGURE 5. Deletion of ybbR does not affect growth or DacA protein production under standard 
growth conditions. A, bacterial growth curves. Overnight cultures of WT LAC* and the ybbR mutant strain 
were diluted to an A600 of 0.01, grown to an A600 of 1 and again back diluted to an A600 of 0.01 (time = 0). 
Growth was subsequently monitored over an 8 h period and average A600 values and standard deviations 
from three independent experiments plotted. B, detection of DacA and YbbR proteins by western-blot. 
Samples were removed at the 2 h and 6 h time points from cultures grown as described in panel A and 
whole cell protein lysates prepared. YbbR and DacA proteins were detected by western-blot using YbbR 
and DacA specific antibodies. A representative blot of three independent experiments is shown.  
  






FIGURE 6. An S. aureus ybbR mutant has increased acid sensitivity. A, bacterial growth on TSA pH 7.3 
versus TSA pH 4.5 plates. WT LAC*, the ybbR mutant, as well as the complementation strain LAC*ΔybbR 
piTET-ybbR (ΔybbR compl.) and the empty vector containing control strains ΔybbR piTET and WT piTET 
were grown overnight in TSB medium. Cultures were then diluted to an A600 of 5 and 10-fold serial dilutions 
ranging from 10-1 to 10-7 prepared and spotted onto TSA pH 7.3 or TSA pH 4.5 containing 200 ng/ml Atet. 
B, detection of YbbR by western-blot. A single colony of the same S. aureus strains as described in panel 
A was used to inoculate TSB containing 200 ng/ml Atet and these starter cultures were incubated for 4 h at 
37°C. Cultures were diluted to an A600 of 0.05 and grown overnight at 37°C in TSB 200 ng/ml Atet before 
preparing whole cell lysates. The YbbR protein and the loading control protein, SrtA were detected by 
western-blot using YbbR and SrtA specific antibodies, respectively. 
 
  





FIGURE 7. Identification of LAC*ΔybbR suppressor strains with improved acid resistance. WT 
LAC*, ΔybbR and ΔybbR suppressor strains (ΔybbR-S1 to S5 and S7 to S11) were grown overnight at 
37°C, cultures normalized to an A600 of 5, and 10-fold dilutions ranging from 10
-1 to 10-6 spotted on TSA 
pH 4.5 plates. 
  





FIGURE 8. S. aureus strain LAC*ΔybbR phenocopies the low c-di-AMP producing LAC*dacAG206S 
strain when challenged with low pH. A, bacterial growth curves in TSB pH 7.3. Cultures of WT LAC* 
and the indicated mutant were diluted to an A600 of 0.05 and grown for 2.5 h. All cultures were then again 
back-diluted to an A600 of 0.05 (time = 0) and bacterial growth monitored for 8 h by determining A600 
readings at timed intervals. The average values and standard deviations from three independent experiments 
are plotted. B-E, bacterial growth curves in TSB pH 4.5. Overnight cultures of WT LAC* and indicated 
mutant or complementation strains were back-diluted to an A600 of 0.05 in TSB pH 4.5 medium and grown 
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FIGURE 9. c-di-AMP levels increase when S. aureus is exposed to low pH, and are raised in the ybbR 
suppressor strains in standard growth medium. A–D, determination of intracellular c-di-AMP levels by 
ELISA. A, cultures of WT LAC* were diluted to an A600 of 0.05 in TSB pH 7.3, TSB pH 4.5 and TSB pH 
4.25; B, cultures of WT LAC* and the indicated mutant strains were diluted to an A600 of 0.05 in TSB pH 
7.3 or TSB pH 4.5. C, cultures of WT LAC* and the indicated mutant strains were diluted to an A600 of 
0.05 in TSB pH 7.3 D, cultures of WT LAC* and the indicated mutant strains were diluted to an A600 of 
0.05 in TSB pH 4.5. All cultures were grown to an A600 of 0.7 and bacteria harvested and cell extracts 
prepared. Lysates were normalized for protein concentration, and cellular c-di-AMP levels determined by 
ELISA and values are reported as ng c-di-AMP/mg protein. The average values and standard deviations 
from three independently prepared cell extracts are plotted. Statistical analysis was performed for panels A 
and B using an unpaired Student’s t-test where one (*), two (**) and three asterisks (***) indicate 
differences between WT and mutant strains or strains grown in TSB pH7.3 versus low pH medium with a 
p-value of <0.05, <0.01 and <0.001, respectively. 
 







FIGURE 10. Schematic representation of proteins involved in the c-di-AMP metabolism of S. aureus. 
c-di-AMP is produced by the di-adenylate cyclase enzyme DacA, which is thought to form a complex with 
YbbR and GlmM. c-di-AMP is degraded by GdpP to pApA, which is further converted by the Pde2 enzyme 
to AMP. pApA can, in a feedback inhibition loop, reduce the activity of GdpP, and the activities of both 
GdpP and Pde2 are inhibited by the stringent response alarmone ppGpp. The results presented in this work 
suggest that yet another PDE Pde3, capable of degrading c-di-AMP to pApA, is present in S. aureus or that 
an alternative pathway for the production of pApA exists. The S. aureus DacA, GpdP, YbbR and GlmM 
proteins have all been detected by western-blot under standard laboratory growth conditions, and based on 
the observed phenotype of the pde2 mutant strain, it is expected that these proteins are produced and present 
at the same time. 
 
 
